You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mecamylamine

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)

Not yet recruiting
  • Subjective Cognitive Decline
  • Mecamylamine Challenge
  • Placebo Comparator Challenge
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Aug 15, 2023

Subjective Cognitive Decline Trial in Nashville (Mecamylamine Challenge, Placebo Comparator Challenge)

Recruiting
  • Subjective Cognitive Decline
  • Mecamylamine Challenge
  • Placebo Comparator Challenge
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Dec 19, 2022

MDD, Substance Use Disorder, Normal Physiology Trial in Baltimore (Placebo Nicotine Patch, Nicotine Patch, Mecamylamine)

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Placebo Nicotine Patch
  • +2 more
  • Baltimore, Maryland
    National Institute on Drug Abuse
Sep 16, 2022

Healthy Aging Trial in Burlington (Nicotine patch, oral mecamylamine, )

Completed
  • Healthy Aging
  • Nicotine patch, oral mecamylamine, placebo
  • Burlington, Vermont
    University of Vermont
Mar 23, 2022

Tachycardia, Chronic Orthostatic Intolerance Trial in Nashville (drug, other, dietary supplement, radiation, procedure, device)

Active, not recruiting
  • Tachycardia
  • Chronic Orthostatic Intolerance
  • Nashville, Tennessee
    Vanderbilt University Autonomic Dysfunction Center
Sep 12, 2022

Spinal Cord Injuries Trial in Detroit (Mecamylamine Oral Tablet)

Unknown status
  • Spinal Cord Injuries
  • Mecamylamine Oral Tablet
  • Detroit, Michigan
    Wayne State University
Oct 2, 2019

Alcoholism Trial in West Haven (mecamylamine, Placebo)

Completed
Has Results
  • Alcoholism
  • mecamylamine
  • Placebo
  • West Haven, Connecticut
    VA Connecticut Healthcare System
May 24, 2019

Magnetic Resonance Imaging, Cognition, Nicotine Trial in Baltimore (Placebo, Nicotine, Mecamylamine)

Completed
Has Results
  • Magnetic Resonance Imaging
  • +3 more
  • Placebo
  • +2 more
  • Baltimore, Maryland
  • +1 more
Aug 15, 2019

Postmenopausal Symptoms, Aging, Alzheimer Trial in Nashville, Burlington (Cholinergic antagonist)

Recruiting
  • Postmenopausal Symptoms
  • +2 more
  • Cholinergic antagonist
  • Nashville, Tennessee
  • +1 more
Mar 23, 2022

Smoking Cessation, Smoking, Cigarette, Smoking Behaviors Trial in Astana (Nicotine patch, Nicotine gums, Brief Advice (5 A's & 5

Not yet recruiting
  • Smoking Cessation
  • +2 more
  • Nicotine patch, Nicotine gums
  • +2 more
  • Astana, Kazakhstan
    Nazarbayev University School of Medicine
Jul 30, 2022

Mental Ability Challenge Study in Adults With and Without HIV

Completed
  • HIV-1-infection
  • +4 more
  • Scopolamine Injectable Product
  • Mecamylamine Pill
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Feb 21, 2019

Nicotine Dependence, Nicotine Withdrawal Trial in Minneapolis (Bupropion, Varenicline)

Completed
Has Results
  • Nicotine Dependence
  • Nicotine Withdrawal
  • Minneapolis, Minnesota
    University of Minnesota, Tobacco Use Research Center
Oct 30, 2020

Nicotinic Modulation of Default Network of Resting Brain

Completed
  • Nicotine Dependence
    • Baltimore, Maryland
    • +1 more
    Jul 3, 2018

    Cognition in Schizophrenia Trial in Boston (Mecamylamine, Varenicline, Placebo)

    Completed
    Has Results
    • Cognition in Schizophrenia
    • Mecamylamine
    • +2 more
    • Boston, Massachusetts
      Freedom Trail Clinic, Massachusetts General Hospital
    Feb 7, 2017

    Autistic Disorder, Pervasive Developmental Disorder Trial in Columbus (mecamylamine, )

    Completed
    • Autistic Disorder
    • Pervasive Developmental Disorder
    • mecamylamine
    • placebo
    • Columbus, Ohio
      Nisonger Center
    Jan 11, 2017

    Alcohol Dependence, Depression Trial in West Haven (Mecamylamine, Placebo)

    Completed
    Has Results
    • Alcohol Dependence
    • Depression
    • Mecamylamine
    • Placebo
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Mar 21, 2016

    Healthy Volunteers, Patients, Pharmacokinetics Trial in Orlando, Minneapolis (TC-5214)

    Completed
    • Healthy Volunteers
    • +3 more
    • Orlando, Florida
    • +1 more
    Mar 14, 2014

    MDD, Depression Trial in India, United States (TC-5214, Placebo)

    Completed
    Has Results
    • Major Depressive Disorder
    • Depression
    • Tuscaloosa, Alabama
    • +50 more
    Mar 14, 2014

    MDD, Depression Trial in Worldwide (TC-5214, Placebo)

    Completed
    Has Results
    • Major Depressive Disorder
    • Depression
    • Brno, Czech Republic
    • +69 more
    Mar 14, 2014

    MDD Trial in Worldwide (TC-5214, Placebo)

    Completed
    Has Results
    • Major Depressive Disorder
    • Buenos Aires, Caba, Argentina
    • +86 more
    Mar 14, 2014

    MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)

    Completed
    Has Results
    • Major Depressive Disorder
    • +2 more
    • Birmingham, Alabama
    • +93 more
    Mar 14, 2014

    MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)

    Completed
    Has Results
    • Major Depressive Disorder
    • Depression
    • Birmingham, Alabama
    • +98 more
    Mar 14, 2014

    Healthy Trial (TC-5214, Placebo)

    Completed
    • Healthy
    • (no location specified)
    Feb 5, 2013

    MDD, Depression Trial in India, United States (TC-5214 + citalopram, Placebo + citalopram)

    Completed
    • Major Depressive Disorder
    • Depression
    • TC-5214 + citalopram
    • Placebo + citalopram
    • Miami, Florida
    • +26 more
    Jun 13, 2013

    MDD Trial in Worldwide (TC-5214, Duloxetine, Placebo)

    Terminated
    Has Results
    • Major Depressive Disorder
    • Beverly Hills, California
    • +66 more
    Nov 14, 2012